Authors:
CAIRNCROSS JG
UEKI K
ZLATESCU MC
LISLE DK
FINKELSTEIN DM
HAMMOND RR
SILVER JS
STARK PC
MACDONALD DR
INO Y
RAMSAY DA
LOUIS DN
Citation: Jg. Cairncross et al., SPECIFIC GENETIC PREDICTORS OF CHEMOTHERAPEUTIC RESPONSE AND SURVIVALIN PATIENTS WITH ANAPLASTIC OLIGODENDROGLIOMAS, Journal of the National Cancer Institute, 90(19), 1998, pp. 1473-1479
Authors:
HERRLINGER U
KRAMM CM
ABOODYGUTERMAN KS
SILVER JS
IKEDA K
JOHNSTON KM
PECHAN PA
BARTH RF
FINKELSTEIN D
CHIOCCA EA
LOUIS DN
BREAKEFIELD XO
Citation: U. Herrlinger et al., PREEXISTING HERPES-SIMPLEX VIRUS-1 (HSV-1) IMMUNITY DECREASES, BUT DOES NOT ABOLISH, GENE-TRANSFER TO EXPERIMENTAL BRAIN-TUMORS BY A HSV-1 VECTOR, Gene therapy, 5(6), 1998, pp. 809-819
Citation: Js. Silver et Hj. Shaffer, CHANGE INTOLERANCE TO SHIFTS IN METHADONE FORMULATION - A PRELIMINARYINVESTIGATION, Journal of substance abuse treatment, 13(4), 1996, pp. 331-339
Citation: Js. Silver, TRUTH, JUSTICE, AND THE AMERICAN WAY - THE CASE AGAINST THE CLIENT PERJURY RULES, Vanderbilt law review, 47(2), 1994, pp. 339-426